500
Participants
Start Date
July 16, 2021
Primary Completion Date
October 31, 2030
Study Completion Date
October 31, 2030
Trio Whole Genome Sequencing and Participant-Specific Research
"The initial evaluation begins with short-read genome sequencing of DNA extracted from blood of affected individual(s) and participating family members (The most common approach will be trio whole genome sequencing, which involves the affected child + their parents).~Additional evaluation may include: functional assessments, animal modeling, reverse phenotyping (may require an interim visit), epigenetic profiling, or clinical database matching through selective sharing of coded patient data with external collaborators (e.g., via Matchmaker Exchange and Phenome Central), long read genome sequencing, de novo genome assembly, RNA sequencing, and novel bioinformatics analyses"
RECRUITING
University of Wisconsin School of Medicine and Public Health, Madison
University of Wisconsin Center for Human Genomics and Precision Medicine
UNKNOWN
University of Wisconsin, Madison
OTHER